Physician profile
Jonathan T Simon
NPI 1073565511
$1,291.14
in general payments reported to CMS, 2019-2025
19 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $231 · 2021: $52.84 · 2022: $13.52 · 2023: $135 · 2024: $89.54 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410 · Education: $16.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.29 |
| Education | $16.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $449.44 | 2019-2025 | Rinvoq, Skyrizi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $172.34 | 2019-2021 | |
| Pfizer INC. | $129.77 | 2019-2025 | |
| Allergan, INC. | $91.85 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $70.57 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.46 | 2019-2020 | |
| Gilead Sciences, INC. | $60.25 | 2022-2023 | |
| Janssen Biotech, INC. | $53.56 | 2019-2024 | Tremfya |
| Qol Medical, LLC | $26.42 | 2020 | |
| Csl Behring | $25.82 | 2023 | Kcentra |
| Ferring Pharmaceuticals INC. | $22.75 | 2019 | |
| Ucb, INC. | $19.07 | 2019 | |
| Braintree Laboratories, INC. | $17.73 | 2019 | |
| Merck Sharp & Dohme LLC | $16.62 | 2019 | |
| Nestle Healthcare Nutrition INC. | $16.11 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $16.00 | 2020 | |
| Shire North American Group INC | $15.20 | 2019 | |
| Shionogi INC | $14.73 | 2019 | |
| Intercept Pharmaceuticals, INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.